News
PBMWW
0.0199
+51.91%
0.0068
Weekly Report: what happened at PBMWW last week (0331-0404)?
Weekly Report · 6d ago
Weekly Report: what happened at PBMWW last week (0324-0328)?
Weekly Report · 03/31 11:17
Weekly Report: what happened at PBMWW last week (0317-0321)?
Weekly Report · 03/24 11:06
Weekly Report: what happened at PBMWW last week (0310-0314)?
Weekly Report · 03/17 11:16
PSYENCE GROUP'S NASDAQ-LISTED ASSOCIATE, PSYENCE BIOMEDICAL, NAMES ALBERT P. GARCIA-ROMEU, PH.D. AS CHAIR OF ITS NEWLY CREATED SCIENTIFIC ADVISORY BOARD
Reuters · 03/10 15:18
Weekly Report: what happened at PBMWW last week (0303-0307)?
Weekly Report · 03/10 11:18
PSYENCE BIOMEDICAL LTD FILES FOR MIXED SHELF OF UP TO $75LN - SEC FILING
Reuters · 03/04 21:47
Weekly Report: what happened at PBMWW last week (0224-0228)?
Weekly Report · 03/03 11:17
PSYENCE BIOMED NAMES ALBERT P. GARCIA-ROMEU, PH.D. AS CHAIR OF ITS NEWLY CREATED SCIENTIFIC ADVISORY BOARD
Reuters · 02/26 13:00
Weekly Report: what happened at PBMWW last week (0217-0221)?
Weekly Report · 02/24 11:17
Weekly Report: what happened at PBMWW last week (0210-0214)?
Weekly Report · 02/17 11:14
Weekly Report: what happened at PBMWW last week (0203-0207)?
Weekly Report · 02/10 11:09
Weekly Report: what happened at PBMWW last week (0127-0131)?
Weekly Report · 02/03 11:13
Weekly Report: what happened at PBMWW last week (0120-0124)?
Weekly Report · 01/27 11:16
Weekly Report: what happened at PBMWW last week (0113-0117)?
Weekly Report · 01/20 11:08
Weekly Report: what happened at PBMWW last week (0106-0110)?
Weekly Report · 01/13 11:09
Weekly Report: what happened at PBMWW last week (1230-0103)?
Weekly Report · 01/06 11:16
Weekly Report: what happened at PBMWW last week (1223-1227)?
Weekly Report · 12/30/2024 11:10
PSYENCE BIOMED ANNOUNCES CLOSING OF $2.0 MILLION PRIVATE PLACEMENT
Reuters · 12/27/2024 21:05
PSYENCE BIOMED ANNOUNCES $2.0 MILLION PRIVATE PLACEMENT
Reuters · 12/23/2024 13:00
More
Webull provides a variety of real-time PBMWW stock news. You can receive the latest news about PSYENCE BIOMEDICAL LTD through multiple platforms. This information may help you make smarter investment decisions.
About PBMWW
More
Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The Company has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.